Table 1 Summary and comparison of patient selection criteria used in established benchmarking systems and in the first phase of EBMT benchmarking system (final column)
Subject attribute | BSBMT —UK | GITMO—Italy | SBSCT—Switzerland | DRST—Germany | BTR—Belgium | ABM—France | GETH —Spain | ABMTRR-Australia/New Zealand | CIBMTR—USA | Phase 1 EBMT |
|---|---|---|---|---|---|---|---|---|---|---|
Year benchmarking commenced | 2010 | 2012 | 1997 | 1998 | 2012 | 2004 | 2017 | 2002 | 1994 | 2019 |
Type of HSCT benchmarked: Allo/Auto | Yes/Yes | Yes/No | Yes/Yes | Yes/Yes | Yes/Yes | Yes/No | Yes/Yes | Yes/Yes | Yes/No | Yes/Yes |
Transplant Number, e.g, 1st, all | All | All | 1st | 1st | All | 1st | All | 1st | 1st | 1st |
No. of transplant years included in analysis cohort | 6 | From 2012 | 20 | 10 | 7 | 5 | 4 | 5 | 3 | 5 |
Centre Inclusion criteria used? Yes/No | No | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | |
Centre inclusion criteria if used e.g. minimum number of transplants or outcome events | N/A | All transplants irrespective of number of HSCT per centre | >20 | >20 “events” | ≥5/year | ≥5/year | EBMT members | N/A | NONE— unstable estimates for less than 10 events | REFER TO TEXT |
